Incannex Healthcare Ltd (ASX:IHL) Stock News, Headlines & Updates
Incannex Healthcare Ltd Stock News from GuruFocus
- 1
May 30, 2024
Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea
Marketwired • 7:00am
May 07, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news